JPMorgan analyst Robbie Marcus downgraded CONMED (NYSE: CNMD) from Overweight to Neutral with a price target of $70.00 (from $85.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE